SW033291 | 15-PGDH inhibitor

SW033291 chemical structure

Available Options

Size:PriceQuantity 
5 mg$80.00
25 mg$275.00
Request Quote / Bulk / Custom Size
Product Inquiry

SW033291 (459147-39-8) is an inhibitor of 15-hydroxyprostaglandin dehydrogenase (IC50 = 1.5 nM) that increases prostaglandin E2 levels in bone marrow and other tissues by inhibiting in vivo degradation of PGE2.1 It accelerated neutrophil recovery, regeneration of platelets and red blood cells, and expanded the numbers of more primitive bone marrow SKL cells in bone marrow transplants. SW033291 also stimulated colon epithelial regeneration in a mouse model of ulcerative colitis. It increased bone formation in mice via PGE2 activation of EP4.2 SW033291 enhanced myogenic differentiation and myotube formation in repairing muscle defects in mice.3 It reduced the severity of pulmonary fibrotic lesions and extracellular matrix remodeling and improved pulmonary function in bleomycin-treated mice.4 It also prevented hepatic ischemia-reperfusion injury in mice.5 SW033291 mitigates oxidative damage, suppresses neuroinflammation, and restores blood-brain barrier integrity in mouse models of Alzheimer’s disease and traumatic brain injury.6 In addition to halting neurodegeneration, it also preserved cognitive function at levels indistinguishable from healthy controls.

References/Citations:

  1. Zhang et al. (2015), Inhibition of the Prostaglandin Degrading Enzyme 15-PGDH Potentiates Tissue Regeneration; Science, 348 aaa2340
  2. Chen et al. (2019), Prostaglandin E2 mediates sensory nerve regulation of bone homeostasis; Nat. Commun., 10 181
  3. Dong et al. (2020), Effects of SW033291 on the myogenesis of muscle-derived stem cells and muscle regeneration; Stem Cell Res. Ther., 11 76
  4. Smith et al. (2020), Therapeutic targeting of 15-PGDH in murine pulmonary fibrosis; Rep., 10 11657
  5. Xie et al. (2022), Effects of small molecule inhibitor SW033291 on hepatic ischemia-reperfusion injury in mice; Biochem. Biophys. Res. Commun., 615 70
  6. Koh et al. (2025), Inhibiting 15-PGDH blocks blood-brain barrier deterioration and protects mice from Alzheimer’s disease and traumatic brain injury; Proc. Natl. Acad. Sci. USA, 122 e2417224122
15-hydroxyprostaglandin dehydrogenase inhibitor, 15-PGDH inhibitor, 459147-39-8, PGDH inhibitor, SW-033291, SW033291, SW033291 supplier

Safety Data Sheet:

Download Safety Data Sheet

Product Data Sheet:

Download Product Data Sheet

Materials provided by Focus Biomolecules are for laboratory research use only and are not intended for human or veterinary applications. Please note that we do not sell to individuals and that all orders placed by non-research organizations will incur a $20 restocking/refund fee

SW033291 (459147-39-8) is an inhibitor of 15-hydroxyprostaglandin dehydrogenase (IC50 = 1.5 nM) that increases prostaglandin E2 levels in bone marrow and other tissues by inhibiting in vivo degradation of PGE2.1 It accelerated neutrophil recovery, regeneration of platelets and red blood cells, and expanded the numbers of more primitive bone marrow SKL cells in bone marrow transplants. SW033291 also stimulated colon epithelial regeneration in a mouse model of ulcerative colitis. It increased bone formation in mice via PGE2 activation of EP4.2 SW033291 enhanced myogenic differentiation and myotube formation in repairing muscle defects in mice.3 It reduced the severity of pulmonary fibrotic lesions and extracellular matrix remodeling and improved pulmonary function in bleomycin-treated mice.4 It also prevented hepatic ischemia-reperfusion injury in mice.5 SW033291 mitigates oxidative damage, suppresses neuroinflammation, and restores blood-brain barrier integrity in mouse models of Alzheimer’s disease and traumatic brain injury.6 In addition to halting neurodegeneration, it also preserved cognitive function at levels indistinguishable from healthy controls.

References/Citations:

  1. Zhang et al. (2015), Inhibition of the Prostaglandin Degrading Enzyme 15-PGDH Potentiates Tissue Regeneration; Science, 348 aaa2340
  2. Chen et al. (2019), Prostaglandin E2 mediates sensory nerve regulation of bone homeostasis; Nat. Commun., 10 181
  3. Dong et al. (2020), Effects of SW033291 on the myogenesis of muscle-derived stem cells and muscle regeneration; Stem Cell Res. Ther., 11 76
  4. Smith et al. (2020), Therapeutic targeting of 15-PGDH in murine pulmonary fibrosis; Rep., 10 11657
  5. Xie et al. (2022), Effects of small molecule inhibitor SW033291 on hepatic ischemia-reperfusion injury in mice; Biochem. Biophys. Res. Commun., 615 70
  6. Koh et al. (2025), Inhibiting 15-PGDH blocks blood-brain barrier deterioration and protects mice from Alzheimer’s disease and traumatic brain injury; Proc. Natl. Acad. Sci. USA, 122 e2417224122